PRME
Prime Medicine, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +9.1% ·
flujo de acciones -15.3% ·
nuevas posiciones netas +8.3%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 78 | +1 | 62.51M | $230.64M | +6 | −5 |
| Q1 2026 | 80 | +2 | 55.31M | $192.04M | +9 | −7 |
| Q4 2025 | 78 | 0 | 56.37M | $195.61M | +1 | −1 |
| Q3 2025 | 18 | +3 | 30.74M | $170.29M | +3 | — |
| Q2 2025 | 12 | +1 | 18.57M | $45.87M | +1 | — |
| Q1 2025 | 8 | 0 | 10.06M | $20.03M | +1 | −1 |
| Q4 2024 | 8 | -1 | 11.48M | $33.53M | +2 | −3 |
| Q3 2024 | 8 | -1 | 11.29M | $43.71M | +1 | −2 |
| Q2 2024 | 9 | — | 11.11M | $57.12M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 4.49M | — | $11.08M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Fidelity (FMR) ✦ | 3.74M | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 3.74M | — | $9.25M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (pasivo) | 3.63M | — | $8.96M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (pasivo) | 3.63M | — | $8.96M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (pasivo) | 3.63M | — | $8.96M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | ARK Investment Management ✦ | 2.32M | -25.0% | $5.74M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (pasivo) | 1.51M | -1.0% | $3.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Geode Capital Management ✦ (pasivo) | 1.51M | -1.0% | $3.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasivo) | 1.24M | +8.2% | $3.06M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 521.51K | Nuevo | $1.29M | 0.0% | New | 1 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 521.51K | Nuevo | $1.29M | 0.0% | New | 1 | SEC ↗ |
| 20 | AQR Capital Management ✦ | 424.36K | +74.1% | $1.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 424.36K | +74.1% | $1.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 424.36K | +74.1% | $1.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 424.36K | +74.1% | $1.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 258.42K | -0.1% | $638,305 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Renaissance Technologies ✦ | 223.40K | -50.1% | $551,798 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Millennium Management ✦ | 148.00K | -91.7% | $365,550 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | T. Rowe Price ✦ | 65.32K | -95.8% | $162,000 | 0.0% | ▼ Trim | 5 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Citadel Advisors | $1.29M | 0.0% |
| Citadel Advisors | $1.29M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 189 tenedores, 97.53M acciones, $314.58M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.